Russell Investments Group’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$710K Buy
92,548
+70,590
+321% +$483K ﹤0.01% 2377
2025
Q4
$43.5K Sell
21,958
-2,695
-11% -$6.11K ﹤0.01% 3353
2025
Q3
$60.6K Buy
24,653
+21,748
+749% +$56K ﹤0.01% 3201
2025
Q2
$7.67K Sell
2,905
-2,742
-49% -$7.37K ﹤0.01% 3379
2025
Q1
$17K Buy
5,647
+2,349
+71% +$7.12K ﹤0.01% 3140
2024
Q4
$8.44K Sell
3,298
-6,318
-66% -$26.3K ﹤0.01% 3176
2024
Q3
$35.8K Buy
9,616
+1,199
+14% +$5.55K ﹤0.01% 2846
2024
Q2
$53.2K Buy
8,417
+5,512
+190% +$36.3K ﹤0.01% 2750
2024
Q1
$15.6K Sell
2,905
-11,861
-80% -$53.7K ﹤0.01% 2801
2023
Q4
$74.1K Buy
14,766
+11,861
+408% +$37.2K ﹤0.01% 2598
2023
Q3
$4.91K Hold
2,905
﹤0.01% 3146
2023
Q2
$8.08K Hold
2,905
﹤0.01% 3009
2023
Q1
$5.29K Buy
+2,905
New +$9.03K ﹤0.01% 2941
2022
Q1
Sell
-113,723
Closed -$691K 2837
2021
Q4
$691K Buy
113,723
+32,502
+40% +$244K ﹤0.01% 2323
2021
Q3
$791K Buy
81,221
+78,738
+3,171% +$866K ﹤0.01% 2286
2021
Q2
$35K Sell
2,483
-138,119
-98% -$2.28M ﹤0.01% 3157
2021
Q1
$3.34M Sell
140,602
-40,091
-22% -$1.04M 0.01% 1571
2020
Q4
$2.41M Buy
180,693
+73,812
+69% +$710K ﹤0.01% 1655
2020
Q3
$741K Buy
+106,881
New +$1.07M ﹤0.01% 2209
2018
Q4
Sell
-17,100
Closed -$63K 2971
2018
Q3
$63K Sell
17,100
-700
-4% -$2.21K ﹤0.01% 2810
2018
Q2
$54K Buy
+17,800
New +$65.9K ﹤0.01% 2801
2017
Q4
Sell
-25,320
Closed -$139K 2976
2017
Q3
$139K Buy
+25,320
New +$156K ﹤0.01% 2731
2017
Q2
Sell
-21,330
Closed -$76K 2990
2017
Q1
$76K Buy
+21,330
New +$105K ﹤0.01% 2851

Other funds holding IBRX